Statistics for Time to Progression of AFP (TPA) as a Predictor of Survival in Hepatocellular Carcinoma Treated with Sorafenib (SOR)
Total visits
| views | |
|---|---|
| Time to Progression of AFP (TPA) as a Predictor of Survival in Hepatocellular Carcinoma Treated with Sorafenib (SOR) | 69 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Time to Progression of AFP (TPA).pdf | 9 |
Top country views
| views | |
|---|---|
| United States | 39 |
| Chile | 18 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 15 |
| Concepcion | 3 |
| Campbell | 1 |
| Sacramento | 1 |
| Zapopan | 1 |